Chongqing Lummy Pharmaceutical Co., Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 1,210.61 million compared to CNY 1,577.61 million a year ago. Revenue was CNY 1,225.22 million compared to CNY 1,583.53 million a year ago.

Net loss was CNY 100.53 million compared to CNY 326.76 million a year ago. Basic loss per share from continuing operations was CNY 0.101 compared to CNY 0.4023 a year ago. Diluted loss per share from continuing operations was CNY 0.101 compared to CNY 0.4023 a year ago.